Alternate‐day dosing of itraconazole in healthy adult cats. Issue 1 (13th April 2015)

• Record Type: Journal Article
• Authors: Middleton, S. M.; Kubier, A.; Dirikolu, L.; Papich, M. G.; Mitchell, M. A.; Rubin, S. I.
• Is Part Of: Journal of veterinary pharmacology and therapeutics. Volume 39:Issue 1(2016)
• Page Start: 27
• Page End: 31
• Publication Date: 2015-04-13
• Subjects: Veterinary pharmacology -- Periodicals; Therapeutics -- Periodicals; 636.0895105
• DOI: 10.1111/jvp.12231
• Languages: English
• ISSNs: 0140-7783

Abstract

Abstract : The current available formulations of itraconazole are not ideal for dosing in cats. The capsular preparation often does not allow for accurate dosing, the oral solution is difficult to administer and poorly tolerated, and the bioavailability of compounded formulations has been shown to be poor in other species. The aim of this study was to evaluate every other day dosing of 100 mg itraconazole capsule in healthy adult cats. Ten healthy adult cats received a 100 mg capsule of itraconazole orally every 48 h for 8 weeks. Peak and trough serum concentrations of itraconazole were measured weekly using high‐performance liquid chromatography (HPLC). Physical examination, complete blood count (CBC), and chemistry profiles were performed weekly. The dosage regimen achieved average therapeutic trough concentrations (>0.5 μ g/mL) within 3 weeks. The protocol yielded no adverse effects in 8 of the 10 study cats, with affected cats recovering fully with discontinuation of the drug and supportive care. At 8 weeks, an average peak concentration of 1.79 ± 0.952 μ g/mL (95% CI: 0.996–2.588) and an average trough concentration of 0.761 ± 0.540 μ g/mL (95% CI: 0.314–1.216) were achieved. Overall, a 100 mg every other day oral dosage regimen for itraconazole in cats yielded serum concentrations with minimal fluctuation and with careful monitoring may be considered for treatment of cats with systemic fungal disease.